Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Stem Cell Lines in Children With Neurofibromatosis Type 1 and Tumors of the Central Nervous System

NCT03332030 is registered in ClinicalTrials.gov with Roger Packer as lead sponsor.

NCT NCT03332030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03332030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Stem Cell Lines in Children With Neurofibromatosis Type 1 and Tumors of the Central Nervous System
Lead sponsor
Roger Packer
Phase
Observational
Overall status
Withdrawn
Start date
November 27, 2015
Completion date
July 1, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 1, tumors of the central nervous system